ChromoCure's new Southeast Research Center to be based in Aventura, Florida

ChromoCure, Inc. (PINKSHEETS: KKUR) announced today its new Southeast Research Center to be based in Aventura, Florida.

The newly planned center is intended as a geographical central hub for direct partnership with cancer diagnostic laboratories and other cancer research centers. The new center will be in addition to the company's operations based in New York.

The new center will be open to pathologists and cancer researchers who wish to tour or utilize the Company's technology.

The company's systems and technology detect the single characteristic found in 100% of all cancers at all stages, and never found in normal cells. The company therefore believes its technology detects cancer with an effective 100% specificity and effective 100% accuracy. The Company's technology also objectively measures, with high precision, the level of cancer present and its stage of progression.

The center will receive a ChromoCure CS200 Chromosomal Scanner and will offer equipment training, theoretical education, and lab support to research and pathology partners.

The center's anticipated opening is during the first quarter of 2010. The launch of this facility is part of the Company's planned geographic expansion as well as providing a base for the Company's upcoming research initiatives to be announced ahead of the opening.